Holen Sie sich die Stockscreener-App
1.78
9.20%
0.15
Handel nachbörslich:
1.92
0.14
+7.87%
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
Maxim Group Maintains MediciNova(MNOV.US) With Buy Rating, Maintains Target Price $6 - Moomoo
3D Investment Partners Updates MediciNova Holdings, Reports Private Sale and Swap Agreements - kalkinemedia.com
Two holders sold 640,000 MediciNova (NASDAQ: MNOV) shares and still report an ownership stake. - Stock Titan
After a sale, an investment manager still reports 4.86 million MediciNova (MNOV) shares held indirectly. - Stock Titan
H.C. Wainwright reiterates Buy on MediciNova stock, $10 target - Investing.com
Why is MediciNova stock sliding today? - Investing.com
Form 8K MediciNova Inc For: 28 September By Investing.com - Investing.com Nigeria
MediciNova extends office lease to 2030 and agrees to rent increases By Investing.com - Investing.com Nigeria
MediciNova Extends Office Lease, Signals Long-Term Stability - TipRanks
Rent increases take effect in February 2027 under MediciNova's (MNOV) amended lease. - Stock Titan
Why Is MediciNova Stock Tumbling Today?MediciNova (NASDAQ:MNOV) - Benzinga
MediciNova Shares Fall After Phase 2 Tipelukast Trial Misses Primary Endpoints - Yahoo Finance
MediciNova stock tumbles on mixed Phase 2 NAFLD trial data - Yahoo Finance
MediciNova misses both Phase 2 endpoints despite HDL gains - Mugglehead Investment Magazine
MediciNova reports mixed phase 2 results for MN-001 drug trial - Investing.com
A 40-person study found more “good” cholesterol with MediciNova's drug, but no significant liver-fat difference. - Stock Titan
MediciNova completes double-blind phase of ALS drug trial By Investing.com - Investing.com Canada
MediciNova completes double-blind phase of ALS drug trial - Investing.com
MediciNova Announces Last Patient, Last Visit in Double-Blind Portion of COMBAT-ALS Phase 2b/3 Trial of MN-166 for ALS - Quiver Quantitative
MediciNova Announces Completion of Last Patient, Last Visit - GlobeNewswire
MediciNova stock trades at USD 2.88 with Q2 cash at USD 25.4 million - AD HOC NEWS
MediciNova Inc (NASDAQ: MNOV) Share Price, MNOV Stock News, MNOV Share Price & Updates - kalkine.com.au
MediciNova, Inc.Common Stock (Nasdaq:MNOV) Price Chart - The Chronicle-Journal
Market Sentiment Around Loss-Making MediciNova, Inc. (NASDAQ:MNOV) - Moomoo
Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Roth MKM Initiates MediciNova(MNOV.US) With Buy Rating, Announces Target Price $6 - Moomoo
Roth/MKM initiates MediciNova stock with buy on ALS drug potential - Investing.com Nigeria
MediciNova, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (MNOV) - Traders Union
Can MediciNova's Upcoming MN-166 And MN-001 Readouts Change The Investment Narrative? - RTTNews
MNOV: Key clinical data from ALS and metabolic trials expected soon, with cash runway secured - TradingView
Medicinova at H.C. Wainwright conference: data, not financing, drives case - Investing.com India
MediciNova to Participate in Two Investor Conferences in September - GlobeNewswire
MediciNova stock gains as price moves above 200-day line - ad-hoc-news.de
MediciNova Ends Standby Equity Financing Agreement - TipRanks
MediciNova (MNOV) ends $30M stock-sale deal after tapping only a fraction of it - Stock Titan
MNOV Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.05 Per Share Highlights Cost DisciplineFree Cash Flow Trends - dars.gov.et
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection - TipRanks
3 Promising Penny Stocks With Over $50M Market Cap - Sahm
Medicinova (MNOV) Outlook: Closes 8.57% Higher at $1.52 in the Latest Reading; Market Levels: $1.44 and $1.60 Define the Nearby Reference Levels in Latest TradingVolatility Smile - vinanet.vn
Medicinova (MNOV) Snapshot: Ends Higher by 1.84% at $1.39 at the Close; Key Range - vinanet.vn
Medicinova (MNOV) Financial Update: Profit Per Share Surpasses Its Benchmark in the Current Update; After Results: The Market Price Declines 2.90% at the CloseEPS Growth Rate - vinanet.vn
MediciNova, Inc. (NASDAQ:MNOV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Form 8K MediciNova Inc For: 19 August By Investing.com - Investing.com Nigeria
MediciNova updates executive employment agreements for CEO and CMO By Investing.com - Investing.com South Africa
MediciNova updates executive employment agreements for CEO and CMO - Investing.com
FY2026 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
Medicinova (MNOV) Holds Steady at $1.31 as Clinical-Stage Biotech Trades Within RangeWave Alternation - Vinanet
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):